Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Safety and Efficacy of Combination Maintenance Therapy with Ixazomib and Lenalidomide in Patients with Posttransplant Myeloma.
Clin Cancer Res. 2022 Apr 1;28(7):1277-1284. doi: 10.1158/1078-0432.CCR-21-3420.
Clin Cancer Res. 2022.
PMID: 34992070
Free PMC article.
Phase I/Ib study of carfilzomib and panobinostat with or without dexamethasone in patients with relapsed/refractory multiple myeloma.
Manasanch EE, Shah JJ, Lee HC, Weber DM, Thomas SK, Amini B, Olsem J, Crumpton B, Morphey A, Berkova Z, Feng L, Orlowski RZ.
Manasanch EE, et al. Among authors: morphey a.
Haematologica. 2020 May;105(5):e242-e245. doi: 10.3324/haematol.2019.225375. Epub 2019 Aug 14.
Haematologica. 2020.
PMID: 31413094
Free PMC article.
Clinical Trial.
No abstract available.
Item in Clipboard
A phase I/II trial of the combination of lenalidomide, thalidomide and dexamethasone in relapsed and/or refractory multiple myeloma.
Lee HC, Shah JJ, Feng L, Morphey A, Johnson RJ, Wesson ET, Wang ML, Alexanian R, Thomas SK, Orlowski RZ, Weber DM.
Lee HC, et al. Among authors: morphey a.
Am J Hematol. 2019 Dec;94(12):E319-E322. doi: 10.1002/ajh.25633. Epub 2019 Oct 4.
Am J Hematol. 2019.
PMID: 31489991
Free article.
Clinical Trial.
No abstract available.
Item in Clipboard
A phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma.
Lee HC, Shah JJ, Feng L, Manasanch EE, Lu R, Morphey A, Crumpton B, Patel KK, Wang ML, Alexanian R, Thomas SK, Weber DM, Orlowski RZ.
Lee HC, et al. Among authors: morphey a.
Blood Cancer J. 2019 Oct 1;9(10):80. doi: 10.1038/s41408-019-0240-6.
Blood Cancer J. 2019.
PMID: 31575851
Free PMC article.
Clinical Trial.
No abstract available.
Item in Clipboard
Management of Ocular Toxicity in Patients Receiving Belantamab Mafodotin.
Lu R, Morphey A, Diaz F, Chen J, Razmandi A, Richards T.
Lu R, et al. Among authors: morphey a.
J Adv Pract Oncol. 2023 May;14(4):300-306. doi: 10.6004/jadpro.2023.14.4.4. Epub 2023 May 1.
J Adv Pract Oncol. 2023.
PMID: 37313276
Free PMC article.
Review.
Item in Clipboard
Cite
Cite